Press release: Everfuel expands management team to drive execution of green hydrogen growth strategy Read more about Press release: Everfuel expands management team to drive execution of green hydrogen growth strategy
Technicolor Creative Studios: 9-Month Update and Q3 2022 Financial Performance Read more about Technicolor Creative Studios: 9-Month Update and Q3 2022 Financial Performance
EDF announces the success of its Hybrid Notes issue for a nominal amount of 1 billion euros and therefore its intention to exercise its Option to Redeem Outstanding USD Hybrid Notes Read more about EDF announces the success of its Hybrid Notes issue for a nominal amount of 1 billion euros and therefore its intention to exercise its Option to Redeem Outstanding USD Hybrid Notes
Veolia Finalizes the Divestment of Antitrust Remedies Agreed With the European Commission Following the Merger With Suez Read more about Veolia Finalizes the Divestment of Antitrust Remedies Agreed With the European Commission Following the Merger With Suez
Umicore: Transparency notification by BlackRock, Inc. Read more about Umicore: Transparency notification by BlackRock, Inc.
Novabase SGPS, S.A. informs about interim report on the transactions conducted under the share buy-back programme Read more about Novabase SGPS, S.A. informs about interim report on the transactions conducted under the share buy-back programme
Additional US$ 4 Million Received for Next Development Steps of MedinCell's 6-Month Active Injectable Bioresorbable Subcutaneous Contraceptive Read more about Additional US$ 4 Million Received for Next Development Steps of MedinCell's 6-Month Active Injectable Bioresorbable Subcutaneous Contraceptive
Séché Environnement: Closing of Acquisition of Veolia’s Industrial Water Treatment Services Business Read more about Séché Environnement: Closing of Acquisition of Veolia’s Industrial Water Treatment Services Business
Onxeo Advances Its Second Lead Candidate OX425 for the Treatment of Solid Tumors Read more about Onxeo Advances Its Second Lead Candidate OX425 for the Treatment of Solid Tumors